Jasper Therapeutics's total assets for Q3 2025 were $57.47M, an increase of 23.68% from the previous quarter. JSPR total liabilities were $45.90M for the fiscal quarter, a 99.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.